Articoli con mandati relativi all'accesso pubblico - Luis Escribano MoraUlteriori informazioni
Non disponibili pubblicamente: 10
Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms
I Alvarez-Twose, D Gonzalez-de-Olano, L Sánchez-Muñoz, A Matito, ...
International archives of allergy and immunology 157 (3), 275-280, 2012
Mandati: Government of Spain
CD 30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis
JM Morgado, O Perbellini, RC Johnson, C Teodósio, A Matito, ...
Histopathology 63 (6), 780-787, 2013
Mandati: Government of Spain
Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis
I Álvarez-Twose, P González, JM Morgado, M Jara-Acevedo, ...
Journal of Clinical Oncology 30 (12), e126-e129, 2012
Mandati: Government of Spain
An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
C Teodosio, AC Garcia-Montero, M Jara-Acevedo, I Álvarez-Twose, ...
Leukemia 26 (5), 951-958, 2012
Mandati: Government of Spain
Diagnosis and classification of mastocytosis in non‐specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients
L Sánchez‐Muñoz, JM Morgado, I Álvarez‐Twose, A Matito, ...
British journal of haematology 172 (1), 56-63, 2016
Mandati: Government of Spain
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia
I Alvarez-Twose, P Martínez-Barranco, J Gotlib, A García-Montero, ...
Leukemia 30 (8), 1753-1756, 2016
Mandati: Government of Spain
Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool
L Sánchez-Muñoz, C Teodosio, JMT Morgado, O Perbellini, A Mayado, ...
Immunology and Allergy Clinics 34 (2), 297-313, 2014
Mandati: Government of Spain
Diagnosis of adult mastocytosis: role for bone marrow analysis
L Escribano, A Garcia‐Montero, L Sanchez‐Muñoz, C Teodosio, ...
Laboratory hematology practice, 388-398, 2012
Mandati: Government of Spain
Characterization of CD34+ hematopoietic cells in systemic mastocytosis: Potential role in disease dissemination
A Mayado, C Teodosio, N Dasilva‐Freire, M Jara‐Acevedo, ...
Allergy 73 (6), 1294-1304, 2018
Mandati: Government of Spain
Management of adult mastocytosis
I Alvarez-Twose, A Matito, L Sánchez-Muñoz, JM Morgado, L Escribano
Expert Opinion on Orphan Drugs 2 (4), 321-336, 2014
Mandati: Government of Spain
Disponibili pubblicamente: 40
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal
P Valent, C Akin, M Arock, K Brockow, JH Butterfield, MC Carter, ...
International archives of allergy and immunology 157 (3), 215-225, 2012
Mandati: US National Institutes of Health, Austrian Science Fund, Government of Spain
Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma …
K Hartmann, L Escribano, C Grattan, K Brockow, MC Carter, ...
Journal of Allergy and Clinical Immunology 137 (1), 35-45, 2016
Mandati: US National Institutes of Health, Austrian Science Fund, German Research …
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
M Arock, K Sotlar, C Akin, S Broesby-Olsen, G Hoermann, L Escribano, ...
Leukemia 29 (6), 1223-1232, 2015
Mandati: US National Institutes of Health, Austrian Science Fund, Government of Spain
Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations
M Castells, DD Metcalfe, L Escribano
American journal of clinical dermatology 12, 259-270, 2011
Mandati: US National Institutes of Health
Advances in the classification and treatment of mastocytosis: current status and outlook toward the future
P Valent, C Akin, K Hartmann, G Nilsson, A Reiter, O Hermine, K Sotlar, ...
Cancer research 77 (6), 1261-1270, 2017
Mandati: US National Institutes of Health, Austrian Science Fund, German Research …
Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis
I Alvarez‐Twose, S Vañó‐Galván, L Sánchez‐Muñoz, JM Morgado, ...
Allergy 67 (6), 813-821, 2012
Mandati: US National Institutes of Health, Government of Spain
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis
P Valent, L Escribano, S Broesby‐Olsen, K Hartmann, C Grattan, ...
Allergy 69 (10), 1267-1274, 2014
Mandati: US National Institutes of Health, Austrian Science Fund
International working group-myeloproliferative neoplasms research and treatment (IWG-MRT) & European competence network on mastocytosis (ECNM) consensus response criteria in …
J Gotlib, A Pardanani, C Akin, A Reiter, T George, O Hermine, ...
Blood, The Journal of the American Society of Hematology 121 (13), 2393-2401, 2013
Mandati: US National Institutes of Health, Austrian Science Fund, Government of Spain
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
P Valent, C Akin, K Hartmann, G Nilsson, A Reiter, O Hermine, K Sotlar, ...
Theranostics 10 (23), 10743, 2020
Mandati: US National Science Foundation, US National Institutes of Health, Austrian …
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal
P Valent, K Sotlar, WR Sperr, L Escribano, S Yavuz, A Reiter, TI George, ...
Annals of oncology 25 (9), 1691-1700, 2014
Mandati: US National Institutes of Health, Austrian Science Fund
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software